HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Vaccaro Selected Research

Radiotherapy

6/2021PDRN, a natural bioactive compound, blunts inflammation and positively reprograms healing genes in an "in vitro" model of oral mucositis.
12/2016Levetiracetam-induced radiation recall dermatitis in a patient undergoing stereotactic radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Vaccaro Research Topics

Disease

8Skin Diseases (Skin Disease)
12/2022 - 03/2009
6Inflammation (Inflammations)
03/2024 - 09/2011
6Vitiligo
01/2023 - 06/2015
5Wounds and Injuries (Trauma)
10/2021 - 05/2008
5Asthma (Bronchial Asthma)
01/2020 - 05/2008
4Actinic Keratosis
05/2024 - 11/2009
4Neoplasms (Cancer)
04/2023 - 04/2020
4Chronic Urticaria
11/2020 - 03/2016
4Psoriasis (Pustulosis Palmaris et Plantaris)
02/2020 - 09/2016
3Acne Vulgaris
11/2023 - 01/2004
3Warts (Wart)
06/2023 - 09/2020
3Telangiectasis (Telangiectasia)
11/2022 - 07/2016
3Infections
10/2022 - 06/2011
3Cicatrix (Scar)
03/2022 - 10/2009
3Stomatitis
02/2022 - 06/2020
3Burns
01/2018 - 05/2008
2Necrobiosis Lipoidica
03/2024 - 12/2014
2Cutaneous Leishmaniasis
09/2023 - 11/2002
2Renal Cell Carcinoma (Grawitz Tumor)
05/2023 - 11/2019
2Atopic Dermatitis (Atopic Eczema)
12/2022 - 01/2020
2Pain (Aches)
10/2022 - 01/2018
2Immune System Diseases (Immune Disorders)
10/2022 - 01/2013
2Neoplasm Metastasis (Metastasis)
08/2022 - 01/2022
2Skin Neoplasms (Skin Cancer)
08/2022 - 02/2012
2Fibrosis (Cirrhosis)
03/2022 - 01/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2020 - 01/2018
2Urticaria (Hives)
01/2020 - 01/2018
2Arthritis (Polyarthritis)
01/2019 - 09/2011
2Erythema
01/2018 - 07/2013
2Contact Dermatitis (Eczema, Contact)
01/2018 - 04/2009
2Alopecia (Baldness)
09/2017 - 03/2015
2Necrosis
03/2017 - 01/2002
2Dermatitis
03/2017 - 01/2014
2Ulcer
12/2014 - 05/2014
2Allergic Contact Dermatitis
01/2014 - 05/2008
1Lentigo (Lentiginosis)
05/2024
1Communicable Diseases (Infectious Diseases)
09/2023
1Osteoporosis
07/2023
1Nervous System Diseases (Neurological Disorders)
06/2023
1Rett Syndrome (Rett's Disorder)
06/2023
1Sarcoidosis (Schaumann Disease)
05/2023
1Headache (Headaches)
10/2022
1Pityriasis
10/2022
1Cytokine Release Syndrome
10/2022
1Folliculitis (Sycosis)
09/2022

Drug/Important Bio-Agent (IBA)

71-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2023 - 12/2014
5CytokinesIBA
12/2022 - 09/2011
4CollagenIBA
03/2024 - 01/2019
4InterleukinsIBA
12/2022 - 06/2015
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 08/2017
4Omalizumab (Xolair)FDA Link
11/2020 - 03/2016
4Proteins (Proteins, Gene)FDA Link
12/2013 - 11/2004
3PolydeoxyribonucleotidesIBA
10/2021 - 05/2008
3caryophylleneIBA
06/2020 - 01/2019
3Imiquimod (Aldara)FDA LinkGeneric
02/2020 - 11/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 05/2008
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2017 - 11/2002
3AntigensIBA
01/2013 - 01/2002
2Ointments (Pastes)IBA
05/2024 - 01/2024
2tirbanibulinIBA
05/2024 - 01/2024
2GenisteinIBA
07/2023 - 02/2012
2pazopanibFDA Link
05/2023 - 11/2019
2Cetuximab (Erbitux)FDA Link
04/2023 - 01/2016
2Interleukin-33IBA
12/2022 - 09/2016
2Biomarkers (Surrogate Marker)IBA
10/2022 - 08/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 05/2008
2ChemokinesIBA
10/2022 - 02/2004
2Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2021 - 06/2021
2CateninsIBA
06/2021 - 02/2020
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2020 - 01/2019
2salicylhydroxamic acid (SHAM)IBA
02/2020 - 03/2017
2Petrolatum (Vaseline)FDA Link
02/2020 - 03/2017
2Histamine Antagonists (Antihistamines)IBA
01/2020 - 03/2016
2Immunoglobulin E (IgE)IBA
01/2020 - 03/2016
2Malondialdehyde (Propanedial)IBA
02/2018 - 01/2002
2Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2017 - 05/2008
2Interleukin-23 (Interleukin 23)IBA
03/2017 - 06/2015
2EnzymesIBA
09/2016 - 06/2015
2AutoantigensIBA
06/2011 - 11/2004
2AntibodiesIBA
11/2004 - 01/2002
1GlucocorticoidsIBA
07/2023
1Alendronate (Alendronate Sodium)FDA LinkGeneric
07/2023
1Paclitaxel (Taxol)FDA LinkGeneric
04/2023
1Cisplatin (Platino)FDA LinkGeneric
04/2023
1Immunoglobulin G (IgG)IBA
10/2022
1VaccinesIBA
10/2022
1ChAdOx1 nCoV-19IBA
10/2022
1BNT162 VaccineIBA
10/2022
1InterferonsIBA
10/2022
1Interleukin-17 (Interleukin 17)IBA
10/2022
1Cytokine Receptors (Cytokine Receptor)IBA
10/2022
1LigandsIBA
10/2022
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
10/2022
1Janus KinasesIBA
10/2022
1ivacaftor drug combination tezacaftorIBA
09/2022

Therapy/Procedure

15Therapeutics
05/2024 - 12/2014
13Photochemotherapy (Photodynamic Therapy)
03/2024 - 03/2009
2Drug Therapy (Chemotherapy)
11/2022 - 06/2021
2Radiotherapy
06/2021 - 12/2016
1Phototherapy (Light Therapy)
12/2022